Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
Abstract Fluid biomarkers are currently measured in cerebrospinal fluid and blood for Alzheimer's disease diagnosis and are promising targets for drug development and for patients’ follow‐up in clinical trials. These biomarkers have been grouped in an unbiased research framework, the amyloid (A...
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Wiley
2023-07-01
|
| Σειρά: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1002/dad2.12465 |